• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-....
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2000-2009  

Glioma, melatonin, and radiotherapy

Print Email
Published on Wednesday, 20 April 2016

Glioma, melatonin, and radiotherapy

 



Download the complete article

 

About this Letter to the Editor.

 

See also:

- About Melatonin;

- Recurrent Glioblastoma Multiforme (grade IV – WHO 2007): a case of complete objective response achieved by means of the concomitant administration of Somatostatin and Octreotide – Retinoids – Vitamin E – Vitamin D3 – Vitamin C – Melatonin – D2 R agonists (Di Bella Method – DBM) associated with Temozolomide;

- Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonisn, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report;

- The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer;

- The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer;

- Complete objective response to biological therapy of plurifocal breast carcinoma.

Search

Follow us...

Latest

  • Melatonin: The smart molecule that differentially modulates autophagy in tumor and normal placental cells
  • Melatonin Alleviates Radiation-Induced Lung Injury via Regulation of miR-30e/NLRP3 Axis
  • Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial
  • Pan-cancer Genomic Analyses Reveal Prognostic and Immunogenic Features of the Tumor Melatonergic Microenvironment Across 14 Solid Cancer Types
  • PK-PD based optimal dose and time for orally administered supra-pharmacological dose of melatonin to prevent radiation induced mortality in mice
  • Acromegaly associated with GIST, non-small cell lung cancer, clear cell renal cancer, myeloma multiplex, medulla oblongata tumor, adrenal adenoma and follicular thyroid nodules
  • Ascorbic acid and beta-carotene as modulators of oxidative damage
  • Prospective study of serum selenium levels and incident esophageal and gastric cancers
  • Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
  • Vitamin E: Regulatory Role on Signal Transduction
  • Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro
  • Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation
  • Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy
  • Dietary vitamin E intake could reduce the risk of lung cancer: evidence from a meta-analysis
  • Tocopherol and local X-ray irradiation of two transplantable rat tumours
  • Chemopreventive effects of early-stage and late-stage supplementation of vitamin E and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet
  • Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
  • RNA-Seq transcriptome analysis shows anti-tumor actions of melatonin in a breast cancer xenograft model

Most Read

  • All-trans-retinoic acid and cancer
  • The Di Bella Method (DBM)
  • Biography
  • About melatonin - 1996
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Vademecum
  • Frequently Asked Questions
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways